is semaglutide on the fda shortage list says that GLP-1 over FDA declares semaglutide (Ozempic/Wegovy) shortage

,

Germanys positive benefit rating for tirzepatide enabled higher negotiated pricing, whereas the United Kingdoms narrower BMI eligibility dampens total addressable population

The potential of GLP-1 agonists in weight loss has been a topic of ongoing discussion, but FDA approval for obesity has only been granted in the past decade

FDA Probes GLP-1 Receptor Agonists on Reports of Suicidal Thoughts, Hair Loss

Unlike compounded drugs, these medications pass rigorous FDA reviews that certify their safety, efficacy, and dosing consistency

ResMeds CEO also addressed regulatory concerns, stating his intention to lobby the incoming administration in Washington D.C